600
Participants
Start Date
April 27, 2021
Primary Completion Date
December 28, 2021
Study Completion Date
January 31, 2022
Sargramostim
All patients randomized to the sargramostim treatment arm will be treated with 250 mcg inhaled sargramostim administered via a vibrating mesh nebulizer once daily for 5 days.
Placebo
All patients in the control arm will receive an equivalent volume of inhaled placebo diluent administered via a vibrating mesh nebulizer once daily for 5 days.
Instituto Medico de la Fundacion Estudios Clinicos, Rosario
Centro de Investigaciones Medicas Mar del Plata, Mar del Plata
Richmond University Medical Center, Staten Island
TruCare Internal Medicine and Infectious Disease, DuBois
TidalHealth Peninsula Regional, Inc., Salisbury
Monroe Biomedical Research, Monroe
Urgent Care Clinical Trials @ AFC Urgent Care - Easley, Easley
Paramount Research Solutions, College Park
Gwinnett Research Institute, LLC, Buford
Indago Research & Health Center, Inc. (Subject Visits Only), Hialeah
Encore Medical Research, Hollywood
IMIC Inc., Palmetto Bay
Invesclinic US, LLC., Fort Lauderdale
Encore Medical Research of Weston, Weston
Synergy Healthcare, Bradenton
University Diabetes & Endocrine Consultants, Chattanooga
Olive Branch Family Medical Center, Olive Branch
Hometown Urgent Care and Research, Columbus
Hometown Urgent Care and Research, Cincinnati
Urgent Care Specialists, LLC DBA Hometown Urgent Care and Research, Dayton
Revival Research Institute, LLC., Sterling Heights
Revive Research Institute, Inc., Farmington Hills
Great Plains Health, North Platte
Applied Research Center of Arkansas, Little Rock
SMS Clinical Research, LLC, Mesquite
UCCT @ City Doc Urgent Care-McKinney, Dallas
Dorrington Medical Associates, Houston
Encore Imaging & Medical Research, Houston
Novotrial Research Group, Pearland
Sun Research Institute, San Antonio
Invesclinic US LLC, Edinburg
University of Utah Health, Salt Lake City
West Valley Research Clinic, LLC, Phoenix
Excel Clinical Research, Las Vegas
Hope Clinical Research, Canoga Park
Benchmark Research, Colton
Sanatorio Santa Barbara, Buenos Aires
Lead Sponsor
United States Department of Defense
FED
Partner Therapeutics, Inc.
INDUSTRY